
Source briefing
EMA recommends authorisation of Rasonque for metastatic pancreatic cancer
EMA’s human medicines committee (CHMP) has recommended granting a marketing authorisation in the European Union for Rasonque (daraxonrasib), an oral treatment for adults with…
Read →
Source briefing
Human medicines European public assessment report (EPAR): Opuviz, aflibercept, Date of authorisation: 13/11/2024, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Opuviz, aflibercept, Date of authorisation: 13/11/2024, Revision: 5, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 10, Status: Authorised
Read →
Source briefing
How can a book make you cry?
New Nobel laureate Karl Deisseroth draws line from his early interest in power of words to research on how brain works
Read →
Source briefing
Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 7, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Dovprela (previously Pretomanid FGK), pretomanid, Date of authorisation: 31/07/2020, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Dovprela (previously Pretomanid FGK), pretomanid, Date of authorisation: 31/07/2020, Revision: 16, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Pritor, telmisartan, Date of authorisation: 11/12/1998, Revision: 31, Status: Withdrawn
Human medicines European public assessment report (EPAR): Pritor, telmisartan, Date of authorisation: 11/12/1998, Revision: 31, Status: Withdrawn
Read →
Source briefing
Evaluating the impact and cost-effectiveness of typhoid conjugate vaccine schedules across diverse settings: A multi-model comparison
by Catherine G. C. Wenger, Kyra H. Grantz, Tigist F. Menkir, Alina M. Muellenmeister, Zeaan Pithawala, Raymond Hutubessy, Vittal Mogasale, Alicia N. M. Kraay, Nick Scott, Romesh G. Abeysuriya, Jason R. Andrews, Jillian Gauld, Nathan C. Lo, Virginia…
Read →
Source briefing
Living longer, disease-free
Healthy Aging Symposium convenes experts to discuss everything from ‘Nutrition 3.0’ to biology of dogs
Read →
Source briefing
Human medicines European public assessment report (EPAR): Revatio, sildenafil, Date of authorisation: 28/10/2005, Revision: 55, Status: Authorised
Human medicines European public assessment report (EPAR): Revatio, sildenafil, Date of authorisation: 28/10/2005, Revision: 55, Status: Authorised
Read →